Xing Yujie, Li Tian, Mao Zhen, Zhao Lei, Sun Yue, Jiang Qitong, Wang Chuanyue, Bo Qijing
Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
Front Psychiatry. 2025 May 19;16:1527054. doi: 10.3389/fpsyt.2025.1527054. eCollection 2025.
Suicide is the primary cause of death in patients with major depressive disorder (MDD) or bipolar disorder (BD). Among various personality traits, neuroticism is particularly relevant to suicide risk. However, its role in MDD and BD has not been examined sufficiently. This study characterized neuroticism in patients with MDD or BD, and analyzed the association between neuroticism and suicide risk in these patients.
This study collected demographic information and personality traits of MDD and BD patients. Group differences were assessed using t-tests, chi-square tests, and Mann-Whitney U tests. To identify factors associated with suicide risk, correlation analysis was first conducted, followed by bivariate and generalized ordered logistic regression for significant variables, including neuroticism. Sensitivity analyses were performed by progressively excluding potential confounders to evaluate the robustness of neuroticism's effect. Additionally, simple mediation analyses using a bootstrap approach were conducted to examine whether depressive symptoms mediated the association between neuroticism and suicide risk in MDD and BD separately. A two-tailed < 0.05 was considered statistically significant.
The study population comprised 88 MDD patients and 90 BD patients. Lifetime suicide risk was present in 39.3% of the study population. In the entire sample, neuroticism was significantly associated with both lifetime ( = 0.18, = 0.018) and current suicide risk ( = 0.17, = 0.024). In patients with MDD, through mediation analysis, neuroticism predicted both depressive symptom severity (B = 0.25, < 0.001) and current suicide risk (B = 0.02, = 0.022), while also indirectly influencing current suicide risk through depressive symptoms (B = 0.01, 95% CI = 0.01-0.02). In BD patients, neuroticism predicted depressive symptoms (B = 0.13, = 0.002) but not current suicide risk (B < 0.01, = 0.714), while depressive symptoms fully mediated this relationship (B = 0.06, < 0.001).
Neuroticism plays a significant role in influencing suicide risk among MDD and BD, through its effect on depressive symptoms. Interventions for neuroticism can reduce depressive symptoms and suicide risk. This highlights the necessity of identification and management of neuroticism in suicide prevention strategies.
自杀是重度抑郁症(MDD)或双相情感障碍(BD)患者的主要死因。在各种人格特质中,神经质与自杀风险尤为相关。然而,其在MDD和BD中的作用尚未得到充分研究。本研究对MDD或BD患者的神经质进行了特征描述,并分析了这些患者中神经质与自杀风险之间的关联。
本研究收集了MDD和BD患者的人口统计学信息和人格特质。使用t检验、卡方检验和曼-惠特尼U检验评估组间差异。为了确定与自杀风险相关的因素,首先进行相关分析,然后对包括神经质在内的显著变量进行双变量和广义有序逻辑回归。通过逐步排除潜在混杂因素进行敏感性分析,以评估神经质效应的稳健性。此外,采用自举法进行简单中介分析,以分别检验抑郁症状是否介导了MDD和BD中神经质与自杀风险之间的关联。双侧P<0.05被认为具有统计学意义。
研究人群包括88例MDD患者和90例BD患者。39.3%的研究人群有终身自杀风险。在整个样本中,神经质与终身自杀风险(r = 0.18,P = 0.018)和当前自杀风险均显著相关(r = 0.17,P = 0.024)。在MDD患者中,通过中介分析,神经质预测了抑郁症状严重程度(B = 0.25,P<0.001)和当前自杀风险(B = 0.02,P = 0.022),同时也通过抑郁症状间接影响当前自杀风险(B = 0.01,95%CI = 0.01 - 0.02)。在BD患者中,神经质预测了抑郁症状(B = 0.13,P = 0.002)但未预测当前自杀风险(B<0.01,P = 0.714),而抑郁症状完全介导了这种关系(B = 0.06,P<0.001)。
神经质通过对抑郁症状的影响,在影响MDD和BD患者的自杀风险中起重要作用。针对神经质的干预可以减轻抑郁症状并降低自杀风险。这突出了在自杀预防策略中识别和管理神经质的必要性。